Tag: postmarket surveillance
Real-World Evidence Sources for Drug Safety: Registries and Claims Data
Registries and claims data are two key sources of real-world evidence used to monitor drug safety after approval. They offer complementary strengths - detailed clinical insight versus massive population coverage - and are now essential tools for regulators and drugmakers.
- March 18 2026
- Tony Newman
- 0 Comments